VMAT SX1

Rx: 63Gy/35fx

2012 AAMD / ROR Plan Challenge

2:01 VMAT treatment field delivery time

Beams
DVH
Simple DVH Metrics

Name (ID): Z002443-LUNG, AAPM (AAPM Z002443-LUNG)
Plan or PlanSum ID: 4arcIDb

Structure ID Structure Code Patient Structure DVH Objective Evaluator Variation Priority Met Achieved
PTV63   PTV63 V63.0Gy[%] >=95 90   Goal 95.30 %
PTV63   PTV63 V59.85Gy[%] >=99 97   Goal 99.85 %
PTV63   PTV63 D0.03cc[Gy] <=67 72.3   Variation 67.132 Gy
GTV63   GTV63 V63.0Gy[%] >=99 97   Goal 99.31 %
SPINAL_CORD   SPINAL_CORD D0.03cc[Gy] <45     Goal 29.919 Gy
TOTAL LUNG - GTV   TOTAL LUNG - GTV V20.0Gy[%] <=24 35   Variation 26.13 %
TOTAL LUNG - GTV   TOTAL LUNG - GTV Mean[Gy] <=16 21   Variation 16.198 Gy
TOTAL LUNG - GTV   TOTAL LUNG - GTV V10.0Gy[%] <=40 55   Goal 39.21 %
HEART   HEART V50.0Gy[%] <=2 8   Goal 1.74 %
ESOPHAGUS   ESOPHAGUS Mean[Gy] <=15 30   Variation 20.452 Gy
PERIPHERAL RING   PERIPHERAL RING V53.55Gy[cc] <=0 30   Goal 0.00 cc
LEFT_LUNG   LEFT_LUNG V10.0Gy[%] <=30 40   Goal 22.00 %
ScoreCard Metrics
Technical Plan Creation Comments

This five (5) partial VMAT arc plan utilized manually selected gantry start-stop positions which avoided entrance through the contralateral lung in the transverse view.  There were few challenges with this case and the metrics with opportunity for significant improvement were the mean dose to the esophagus and improved target homogeneity.  Even accounting for those metrics, this VMAT plan scored higher than every case submitted to the lung plan study that year.  This high score is probably attributable to the two-stage, stacked and staggered MLC design with reduced interleaf leakage compared to previous designs and also attributable to Eclipse improvements since the  study was held (namely: intermediate dose calculation).  With this partial arc VMAT arrangement, there seemed to be no penalty to employing the VMAT technique on this case as it scored between the eight (8) and ten (10) field IMRT plans and the treatment time was slightly faster.

Physician Comments

See Lung-Advanced Stage (IMRT)

Comparative Plan Quality
Links

3rd party software plan report

PDF

  Dosimetric ScoreCard

JSON 

DICOM patient export   

ZIP        

Any reference to a "plan study" are simply what the organizers call each case and may not be a "study" in the FDA sense as they may not have been published in a peer reviewed journal.
Varian does not provide medical advice and these are illustrative examples only.
Leading plans by expert planner. Your results may vary.

FOR EDUCATIONAL AND SCIENTIFIC EXCHANGE ONLY – NOT FOR SALES OR PROMOTIONAL USE.